Akinori Ueda
Stock Analyst at Goldman Sachs
(2.75)
# 2,957
Out of 4,659 analysts
50
Total ratings
43.8%
Success rate
5%
Average return
Main Sectors:
Stocks Rated by Akinori Ueda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4528 Ono Pharmaceutical Co., Ltd. | Maintained: Sell | ¥2,200 | ¥2,449 | -10.17% | 1 | Aug 14, 2026 | |
| TYO: 7733 Olympus Corporation | Maintained: Hold | ¥2,050 → ¥2,300 | ¥2,118 | +8.59% | 6 | Aug 10, 2026 | |
| TYO: 6869 Sysmex Corporation | Maintained: Buy | ¥2,000 → ¥1,950 | ¥1,891 | +3.12% | 3 | Aug 10, 2026 | |
| TYO: 2413 M3, Inc. | Maintained: Hold | ¥1,850 → ¥1,750 | ¥1,733 | +0.98% | 6 | Aug 7, 2026 | |
| LINK Interlink Electronics | Maintained: Buy | n/a | $5.13 | - | 1 | Jun 15, 2026 | |
| TYO: 4519 Chugai Pharmaceutical Co., Ltd. | Upgraded: Buy | ¥8,950 | ¥6,876 | +30.16% | 3 | Jun 15, 2026 | |
| TYO: 4507 Shionogi & Co., Ltd. | Upgraded: Buy | ¥3,300 → ¥3,400 | ¥2,846 | +19.47% | 2 | Jun 15, 2026 | |
| TYO: 4578 Otsuka Holdings Co., Ltd. | Maintained: Buy | ¥11,900 → ¥12,400 | ¥12,135 | +2.18% | 9 | Apr 30, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Rated: Buy | ¥4,900 → ¥4,300 | ¥2,729 | +57.60% | 3 | Apr 15, 2026 | |
| TYO: 4587 PeptiDream Inc. | Maintained: Buy | ¥3,000 → ¥2,750 | ¥1,022 | +169.21% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | ¥2,500 → ¥2,250 | ¥2,591 | -13.16% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $49.48 | n/a | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ¥3,700 | ¥5,727 | n/a | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥5,000 | ¥2,450 | n/a | 1 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4,813.00 | n/a | 1 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $18.05 | n/a | 2 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $13.29 | n/a | 1 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2,316.00 | n/a | 1 | Jun 8, 2018 |
Ono Pharmaceutical Co., Ltd.
Aug 14, 2026
Maintained: Sell
Price Target: ¥2,200
Current: ¥2,449
Upside: -10.17%
Olympus Corporation
Aug 10, 2026
Maintained: Hold
Price Target: ¥2,050 → ¥2,300
Current: ¥2,118
Upside: +8.59%
Sysmex Corporation
Aug 10, 2026
Maintained: Buy
Price Target: ¥2,000 → ¥1,950
Current: ¥1,891
Upside: +3.12%
M3, Inc.
Aug 7, 2026
Maintained: Hold
Price Target: ¥1,850 → ¥1,750
Current: ¥1,733
Upside: +0.98%
Interlink Electronics
Jun 15, 2026
Maintained: Buy
Price Target: n/a
Current: $5.13
Upside: -
Chugai Pharmaceutical Co., Ltd.
Jun 15, 2026
Upgraded: Buy
Price Target: ¥8,950
Current: ¥6,876
Upside: +30.16%
Shionogi & Co., Ltd.
Jun 15, 2026
Upgraded: Buy
Price Target: ¥3,300 → ¥3,400
Current: ¥2,846
Upside: +19.47%
Otsuka Holdings Co., Ltd.
Apr 30, 2026
Maintained: Buy
Price Target: ¥11,900 → ¥12,400
Current: ¥12,135
Upside: +2.18%
Daiichi Sankyo Company, Limited
Apr 15, 2026
Rated: Buy
Price Target: ¥4,900 → ¥4,300
Current: ¥2,729
Upside: +57.60%
PeptiDream Inc.
Feb 17, 2026
Maintained: Buy
Price Target: ¥3,000 → ¥2,750
Current: ¥1,022
Upside: +169.21%
Dec 16, 2025
Downgraded: Sell
Price Target: ¥2,500 → ¥2,250
Current: ¥2,591
Upside: -13.16%
Jul 19, 2023
Reiterated: Buy
Price Target: $40
Current: $49.48
Upside: n/a
Jan 13, 2022
Downgraded: Hold
Price Target: ¥3,700
Current: ¥5,727
Upside: n/a
Dec 21, 2021
Reiterated: Hold
Price Target: ¥5,000
Current: ¥2,450
Upside: n/a
Jun 16, 2021
Maintained: Hold
Price Target: n/a
Current: $4,813.00
Upside: n/a
Apr 19, 2021
Maintained: Buy
Price Target: n/a
Current: $18.05
Upside: n/a
Dec 20, 2018
Upgraded: Buy
Price Target: n/a
Current: $13.29
Upside: n/a
Jun 8, 2018
Downgraded: Hold
Price Target: n/a
Current: $2,316.00
Upside: n/a